Propylthiouracil: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Propylthiouracil. Educational only — not medical advice.
Labeled uses
Propylthiouracil tablets are indicated: in patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole
Source: FDA labeling via NIH DailyMed (set 804fa92a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.